Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-05-24 Purchase | 2022-05-25 8:03 pm | DURECT CORP | DRRX | AZAB MOHAMMAD Director | 30,000 | $0.38793 | $11,638 | 60,000 (Direct) | View |
2022-05-16 Purchase | 2022-05-18 8:05 pm | DURECT CORP | DRRX | AZAB MOHAMMAD Director | 30,000 | $0.40578 | $12,174 | 30,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-09-25 Option Award | 2024-09-27 4:16 pm | N/A 2034-09-25 | DURECT CORP | DRRX | AZAB MOHAMMAD Director | 5,500 | $0 | 5,500 (Direct) | View |
2024-01-09 Option Award | 2024-01-11 4:02 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | AZAB MOHAMMAD Director | 19,480 | $0 | 58,680 (Direct) | View |
2023-12-19 Exercise | 2023-12-20 5:04 pm | 2016-12-31 2024-01-13 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 4,320 | $0 | 74,225 (Direct) | View |
2023-12-19 Exercise | 2023-12-20 5:04 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 4,320 | $9.85 | 74,225 (Direct) | View |
2023-06-21 Option Award | 2023-06-23 5:29 pm | N/A 2033-06-21 | DURECT CORP | DRRX | AZAB MOHAMMAD Director | 5,500 | $0 | 5,500 (Direct) | View |
2023-06-02 Option Award | 2023-06-02 5:29 pm | N/A 2033-06-01 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 18,475 | $0 | 18,475 (Direct) | View |
2023-01-09 Option Award | 2023-01-11 4:12 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | AZAB MOHAMMAD Director | 20,000 | $0 | 39,200 (Direct) | View |
2022-12-12 Exercise | 2022-12-13 4:29 pm | N/A 2022-12-31 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 3,086 | $0 | 69,905 (Direct) | View |
2022-12-12 Exercise | 2022-12-13 4:29 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 3,086 | $2.68 | 69,905 (Direct) | View |
2022-09-15 Option Award | 2022-09-16 4:46 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | AZAB MOHAMMAD Director | 19,200 | $6.25 | 19,200 (Direct) | View |
2022-06-28 Option Award | 2022-06-29 5:23 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 18,000 | $0 | 18,000 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 4:07 pm | N/A 2032-06-15 | DURECT CORP | DRRX | AZAB MOHAMMAD Director | 55,000 | $0 | 55,000 (Direct) | View |
2021-12-15 Exercise | 2021-12-17 4:04 pm | N/A 2021-12-31 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 3,086 | $0 | 66,819 (Direct) | View |
2021-12-15 Exercise | 2021-12-17 4:04 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 3,086 | $3.67 | 66,819 (Direct) | View |
2021-06-15 Option Award | 2021-06-16 4:30 pm | N/A 2031-06-15 | DURECT CORP | DRRX | AZAB MOHAMMAD Director | 27,500 | $0 | 27,500 (Direct) | View |
2021-06-03 Option Award | 2021-06-03 9:02 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-01-04 Option Award | 2021-01-05 8:49 pm | N/A 2031-01-04 | DURECT CORP | DRRX | AZAB MOHAMMAD Director | 70,000 | $0 | 70,000 (Direct) | View |
2020-12-15 Exercise | 2020-12-15 4:39 pm | N/A 2020-12-31 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 3,086 | $0 | 63,733 (Direct) | View |
2020-12-15 Exercise | 2020-12-15 4:39 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 3,086 | $3.76 | 63,733 (Direct) | View |
2020-06-01 Option Award | 2020-06-02 4:56 pm | N/A 2030-05-31 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 10,000 | $0 | 10,000 (Direct) | View |